Inactivation of cell survival factors is a crucial step in apoptosis. The phosphoinositide 3 kinase (PI3K) and AKT signaling pathway promotes cell growth, proliferation and survival and its deregulation causes cancer. How this pathway is suppressed to promote apoptosis is poorly understood. Here we report the identification of a CED-3 caspase substrate in C. elegans, CNT-1, that upon cleavage by CED-3 during apoptosis activates an N-terminal phosphoinositide-binding fragment (tCNT-1), which translocates from cytoplasm to plasma membrane to block AKT binding to phosphatidylinositol (3,4,5)-triphosphate (PIP 3 ), thereby disabling AKT activation and its pro-survival activity. Our findings reveal a new mechanism that negatively regulates AKT cell signaling to promote apoptosis and that may restrict cell growth and proliferation in normal cells.
CED-3 cleavage of the mitochondrial fission protein DRP-1 and the multipass transmembrane protein CED-8 generates C-terminal cleavage products that promote mitochondria elimination and phosphatidylserine externalization in apoptotic cells, respectively 6, 7 . Thus, CED-3 cleavage of DCR-1, DRP-1 and CED-8 activates three different cell disassembly events that facilitate cell killing. In this study, we report a new CED-3 substrate, CNT-1, whose cleavage by CED-3 activates an N-terminal cleavage product, truncated CNT-1 (tCNT-1), that promotes apoptosis by suppressing the AKT prosurvival activity.
In mammals, the PI3K and AKT pathway is critical for cell growth, proliferation, survival, and metabolism 8, 9 . Hyperactivation of this pathway results in cancers, revealing the oncogenic potential of PI3K and AKT signaling components [10] [11] [12] , whereas impaired signaling in this pathway causes diabetes and cardiovascular disease 13, 14 . In C. elegans, the AKT homologues, AKT-1 and AKT-2, act in the insulin and insulin-like growth factor signaling (IIS) pathway to regulate lifespan, development, metabolism, and stress resistance [15] [16] [17] . In the IIS pathway, the insulin receptor-like protein DAF-2 activates the PI3K complex AGE-1/AAP-1 [18] [19] [20] , leading to the generation of PIP 3 on the inner leaflet of the plasma membrane. PIP 3 may then recruit serine-threonine kinases PDK-1, AKT-1, AKT-2, and SGK-1 to the plasma membrane by engaging their pleckstrin homology (PH) domains [21] [22] [23] , as has been shown with mammalian AKT 9 . PDK-1 likely phosphorylates and activates AKT-1, AKT-2, and SGK-1, which negatively regulate the activity of the forkhead transcription factor DAF-16 24, 25 , preventing its translocation from the cytosol to the nucleus 26, 27 . The PI3K and AKT pathway is negatively regulated by the lipid phosphatase DAF-18 (homologous to human Phosphatase and Tensin Homolog, PTEN), which dephosphorylates and converts PIP 3 to PIP 2 and blocks recruitment of AKT kinases to the plasma membrane [28] [29] [30] [31] . Mutations in components of this pathway lead to changes in lifespan, development, metabolism, and stress responses in C. elegans 32, 33 . In addition, lossof-function (lf) mutations in the akt-1 and akt-2 genes cause hypersensitivity to ionizing radiation-induced germ cell apoptosis 34 , suggesting that AKT kinases also play a prosurvival role in C. elegans.
In this study, we set out to understand how caspases inactivate cell survival factors to promote apoptosis and demonstrate a new mechanism that inactivates AKT kinases. CNT-1, upon cleavage by CED-3, generates tCNT-1 that acquires a potent phosphoinositide-binding activity and translocates from the cytoplasm to the plasma membrane, where it outcompetes AKT kinases for binding to PIP 3 , suppresses the PI3K and AKT cell survival pathway, and promotes apoptosis.
RESULTS

cnt-1 promotes apoptosis downstream of ced-3
To identify genes acting downstream of CED-3 to kill cells, we performed a genetic screen to isolate suppressors of ectopic neuronal death induced by activated CED-3 (acCED-3) 35 and isolated a recessive mutation, sm8, which defines a new gene cps-2 (CED-3 Protease Suppressor) on linkage group (LG) II (METHODS).
We investigated whether cps-2 affects apoptosis by examining embryonic cell death in cps-2(sm8) animals. Compared with wild type N2 embryos, cps-2(sm8) embryos had fewer apoptotic cell corpses in early stages of embryogenesis (comma and 1.5-fold stages) and more cell corpses in later stages (Fig. 1a) , displaying a characteristic delay-of-cell-death phenotype observed in mutants defective in genes acting downstream of ced-3 7, [35] [36] [37] . Threepoint mapping and single-nucleotide polymorphism (SNP) mapping placed cps-2(sm8) at a position of 12,103,628 base pair (bp) on LGII (Fig. 1b) . Since there are no available fosmid or cosmid clones in this region for transformation rescue experiments, we performed an RNA interference (RNAi) screen on nine candidate genes in this region and found that RNAi treatment of cnt-1 caused a similar delay-of-cell-death defect (Supplementary Table  1 ). We then introduced into cps-2(sm8) animals a cnt-1 minigene, which contains a fulllength cnt-1 cDNA fused to 1944 bp of the cnt-1 promoter, and found that it rescued the cps-2(sm8) defect (Fig. 1b and Supplementary Fig. 1a) . Moreover, an existing cnt-1 deletion mutation (tm2313) caused a similar delay-of-cell-death defect and failed to complement cps-2(sm8) (Fig. 1a) , indicating that tm2313 and sm8 are allelic. Sequencing analysis of cps-2(sm8) animals revealed a nucleotide deletion at 927 bp upstream from the cnt-1 translational start, but no mutation in the coding region of cnt-1 and 1031 bp 3′ untranslated region. Since a cnt-1 minigene carrying this nucleotide deletion failed to rescue the cell death defect in cps-2(sm8) animals ( Fig. 1b and Supplementary Fig. 1a ) and since neither cnt-1 mRNA nor CNT-1 protein was detected in cps-2(sm8) animals ( Supplementary Fig.  1b, c) , sm8 likely disrupts a cis-element important for cnt-1 expression. These results indicate that cps-2 is cnt-1. cnt-1(tm2313) was thus used in all subsequent experiments.
We examined whether delay of cell death caused by cnt-1(tm2313) results in survival of cells that normally die, yielding extra "undead" cells in the anterior pharynx of mutant animals 35 . Like wild-type animals, cnt-1(tm2313) animals had few extra undead cells (Supplementary Table 2 ). However, in sensitized backgrounds such as animals weakly defective in ced-3 and ced-4, cnt-1(tm2313) significantly increased the number of extra cells observed in these weak cell death mutants, indicating that cnt-1 promotes apoptosis.
Since sm8 inhibits acCED-3-induced neuronal death, we examined whether cnt-1 functions downstream of ced-3, using an integrated transgene (smIs111) expressing acCED-3 from the egl-1 promoter 38 . The cell death initiating gene egl-1 functions upstream of ced-3 to induce apoptosis and is mainly expressed in dying cells 39 . When we placed smIs111 in the ced-4(n1162) mutant, in which almost all physiological cell deaths are blocked, acCED-3 still induced ectopic cell death (Fig. 1c) . cnt-1(tm2313) significantly reduced the number of ectopic deaths in smIs111; ced-4(n1162) embryos, indicating that cnt-1 likely acts downstream of ced-3 to promote apoptosis.
CNT-1 is cleaved sequentially at two sites by CED-3
Given that cnt-1 acts downstream of ced-3, we tested whether CNT-1 is a substrate of CED-3 protease. We incubated 35 S-Methionine labeled glutathione S-transferase (GST) fusion with the longer CNT-1 isoform, GST-CNT-1a, with CED-3 and found that it was cleaved by CED-3, yielding two species of approximately 68 and 24 kilodalton (kDa) (Fig.  2a) . Since GST-CNT-1a is 116 kDa, this cleavage pattern suggests that the 24 kDa species might contain two cleavage products of similar sizes and that CNT-1a is cleaved at two different sites. Based on the consensus CED-3 cleavage sites (DXXD; X can be any amino acid) 40 , we identified three potential CED-3 cleavage sites, Asp382 (DSVD), Asp508 (DSID), and Asp609 (DVQD). We then generated Aspartic acid to Glutamic acid substitutions in each potential cleavage site, which is named D1, D2 and D3, respectively, and tested CED-3 cleavage of the mutant proteins. The D1E mutation completely abolished cleavage of CNT-1a by CED-3 (Fig. 2a) , suggesting that D1 is required for CED-3 cleavage. The D2E mutation did not alter the cleavage pattern (Fig. 2a) , indicating that D2 is not a CED-3 cleavage site in vitro. The D3E mutation abolished the 24 kDa species, and instead, produced a new 47 kDa band along with the 68 kDa band (Fig. 2a) , confirming that CED-3 cleavage at D3 generates two cleavage products of similar sizes (23 and 24 kDa). Because D1E also blocked cleavage at the D3 site, CED-3 cleavage at the D1 site is required for cleavage at the D3 site. In CNT-1b, a shorter isoform of CNT-1 that has the same 564 amino acid C-terminus, including a pleckstrin homology (PH) domain, but has a different 177-residue N-terminal sequence (Fig. 2b) , three identical CED-3 cleavage sites were found (Asp298, Asp424, and Asp525). We observed similar CED-3 cleavage patterns with GST-CNT-1b and GST-CNT-1b mutants carrying D1E, D2E and D3E, respectively (Fig. 2b) . These data indicate that D1 is the primary CED-3 cleavage site in CNT-1 and is required for subsequent CED-3 cleavage at D3.
To examine if CNT-1 is a CED-3 substrate in vivo, we probed for CNT-1 cleavage products in worm lysates using an antibody raised against the N-terminal cleavage product of CNT-1b (tCNT-1b), which recognizes recombinant tCNT-1b and tCNT-1a ( Supplementary  Fig. 1d ). In wild-type animals, we detected two bands consistent with the sizes of full-length CNT-1a and CNT-1b, which were absent in the cnt-1(tm2313) mutant (Fig. 2c) . The absence of cleaved CNT-1 products is due to the fact that few apoptosis occurs in wild-type embryos. In animals carrying an integrated transgene (smIs82) that induces global expression of death initiator EGL-1 and widespread apoptosis under the control of heatshock promoters (P hsp EGL-1) 6 , the same two bands were observed prior to heat-shock treatment (Fig. 2c) . After heat shock treatment, the intensity of these two bands was reduced and two smaller bands consistent with the sizes of tCNT-1a and tCNT-1b appeared. The appearance of tCNT-1a and tCNT-1b bands was CED-3-dependent, because a ced-3(n717) lf mutation abolished these two bands in smIs82 animals. Therefore, CNT-1 is cleaved by CED-3 in C. elegans.
Cleavage of CNT-1 activates tCNT-1 proapoptotic activity
We determined whether CNT-1 cleavage by CED-3 is important for apoptosis. Expression of CNT-1a or CNT-1b from a globally active dpy-30 promoter fully rescued the delay-ofcell-death defect in cnt-1(tm2313) animals ( Fig. 3a and Supplementary Fig. 2a ). However, P dpy-30 CNT-1a(D1E) and P dpy-30 CNT-1b(D1E), expressing CNT-1 mutants resistant to CED-3 cleavage, did not rescue the cnt-1(tm2313) mutant ( Fig. 3b and Supplementary Fig.  2b ), indicating that cleavage of CNT-1 by CED-3 is critical for its proapoptotic function. Expression of tCNT-1a or tCNT-1b, at 20% of the endogenous CNT-1 level ( Supplementary  Fig. 2c, d ), led to increased cell death in most embryonic stages compared to wild type and cnt-1(tm2313) embryos ( Fig. 3c and Supplementary Fig. 2e ). The increased cell corpses observed in animals carrying P dpy-30 tCNT-1a or P dpy-30 tCNT-1b were due to ectopic cell death, because some pharyngeal cells that normally live were randomly lost in transgenic larvae (Supplementary Table 3 ). In comparison, co-expression of the other two CNT-1a CED-3 cleavage fragments, CNT-1a F2 and CNT-1a F3 (Fig. 2a) , did not induce ectopic cell death or rescue the cnt-1(tm2313) mutant (Fig. 3d) , whereas co-expression of all three CED-3 cleavage products did (Supplementary Fig. 2f ). These results indicate that tCNT-1, activated by CED-3 cleavage, is responsible for CNT-1's proapoptotic activity.
cnt-1 promotes cell death by inhibiting the AKT pathway
Because the only recognizable motif in tCNT-1 is the PH domain (Fig. 2) , a potential phosphoinositide (PI) binding domain 41 , and because one of the PI species, PIP 3 , activates AKT kinases (also containing a PH domain) to promote cell survival 8, 9 , we asked whether C. elegans AKT kinases participate in regulating apoptosis and genetically interact with cnt-1. An activating mutation in akt-1, akt-1(mg144gf) 22 , caused a delay of cell death defect similar to that of the cnt-1(tm2313) mutant (Fig. 4a) . Combination of cnt-1(tm2313) and akt-1(mg144gf) did not enhance this phenotype, suggesting that akt-1 and cnt-1 function in the same pathway. Since the ced-3(n2438); akt-1(mg144gf) double mutant had more extra undead cells than ced-3(n2438) or akt-1(mg144gf) single mutants (Supplementary Table 4 ), this suggests that akt-1 inhibits cell death. Epistasis analysis using animals carrying a P dpy-30 tCNT-1a transgene showed that akt-1(mg144gf) completely blocked ectopic cell death induced by P dpy-30 tCNT-1a (Fig. 4b) , indicating that akt-1 likely acts downstream of cnt-1 to inhibit cell death. Consistently, akt-1(mg144gf) suppressed ectopic cell death induced by smIs111, a transgene expressing acCED-3, to the same extent as cnt-1(tm2313) (Fig. 1c) , indicating that akt-1 can act downstream of CED-3 to promote cell survival.
We also examined animals carrying a lf mutation in akt-1, akt-2 or sgk-1, three AKT kinases acting in parallel in the IIS pathway 22, 23 . akt-1(tm399), akt-2(tm1075), or sgk-1(ok538) each did not cause a detectable cell death defect, whereas all three combinations of double mutations and the triple mutation combination caused increased cell death throughout embryogenesis ( Supplementary Fig. 3a ), indicating that the presence of at least two AKT and SGK kinases is important for cell survival. Since cnt-1(tm2313) failed to suppress ectopic cell death in the triple mutant ( Fig. 4c and Supplementary Table 5), these results suggest that cnt-1 functions upstream of akt-1, akt-2, and sgk-1 to promote cell death.
AKT kinases phosphorylate proteins to transduce signals in various pathways 22, 42, 43 . To examine if the kinase activity of AKT is important for its anti-apoptotic activity, we expressed the kinase-defective mutants of AKT-1 and AKT-2, AKT-1(K222M) and AKT-2(K209M), in the akt-1(tm399); akt-2(tm1075) mutant 22 . Expression of wild type AKT-1 or AKT-2 rescued the increased cell death phenotype of the akt-1(tm399); akt-2(tm1075) mutant, whereas expression of AKT-1(K222M) or AKT-2(K209M) did not ( Supplementary Fig. 4a, b) , indicating that the kinase activity of AKT is required for its prosurvival function.
A key substrate of AKT kinases in the IIS pathway is DAF-16, a homologue of the Foxo transcriptional factor 24, 25, 42 . A daf-16 lf mutation, mu86, caused a delay-of-cell-death defect similar to that of cnt-1(tm2313) or akt-1(mg144gf) animals, but did not enhance their cell death defects ( Supplementary Fig. 3b, c) , indicating that daf-16, akt-1 and cnt-1 function in the same pathway to affect apoptosis. Moreover, daf-16(mu86) fully suppressed ectopic cell death induced by tCNT-1a ( Supplementary Fig. 3d ) and increased the number of extra undead cells in ced-3(n2438) animals (Supplementary Table 4 ), suggesting that daf-16 acts downstream of cnt-1 to promote cell death.
cnt-1 acts downstream of PI3K to promote cell death
C. elegans AKT kinases are likely activated by PIP 3 and thus regulated by AGE-1, a PI3K that phosphorylates PIP 2 to generate PIP 3 19,20 . An age-1(mg44) lf mutation caused an increased cell death phenotype similar to that of akt-1(tm399); akt-2(tm1075) sgk-1(ok538) animals ( Fig. 4c, d ), but did not enhance the increased cell death phenotype caused by P dpy-30 tCNT-1a ( Supplementary Fig. 3e ), suggesting that age-1 inhibits and tCNT-1 promotes apoptosis in the same pathway. Opposite to what was observed with the akt-1(lf); akt-2(lf) sgk-1(lf) triple mutant (Fig. 4c) , cnt-1(tm2313) blocked both the increased cell death and the missing cell phenotypes caused by age-1(mg44) (Fig. 4d and Supplementary 
Cleavage of CNT-1 activates its phosphoinositide binding
Given that age-1 activates AKT kinases through PIP 3 and daf-18 inactivates this pathway through dephosphorylation of PIP 3 , we hypothesized that tCNT-1, with a PH domain, promotes cell death by interfering with the binding of PIP 3 by AKT kinases. We examined whether tCNT-1 binds PIP 3 using an in vitro lipid-binding assay. 35 S-Met labeled GST-CNT-1a on its own did not bind any lipid, but showed strong binding to PIP, PIP 2 and PIP 3 and weak binding to phosphatidic acid (PA) and cardiolipin (CL) after pre-treated with CED-3 ( Fig. 5a ). GST-tCNT-1a displayed an identical lipid-binding pattern to that of CED-3-treated GST-CNT-1a (Fig. 5a ). So did GST-CNT-1b pretreated with CED-3 and GST-tCNT-1b (Fig. 5a ). When we altered one of the highly conserved, phosphoinositidebinding lysine residues in the PH domain of CNT-1a (K284A) 44 , neither CNT-1a(K284A) pretreated with CED-3 nor tCNT-1a(K284A) showed any lipid-binding activity (Fig. 5a) . Moreover, expression of CNT-1a(K284A) or tCNT-1a(K284A) in cnt-1(tm2313) animals did not rescue the cell death defect or cause ectopic cell death (Fig. 3e, f) . Since the K284A mutation did not alter the expression levels of CNT-1a proteins in vitro or in vivo ( Supplementary Fig. 5 ), these results indicate that the PH domain is required for tCNT-1 to acquire phosphoinositide-binding after CED-3 cleavage and to promote apoptosis.
tCNT-1 blocks PIP 3 binding by AKT and SGK kinases
We tested whether tCNT-1 interferes with binding of AKT and SGK kinases to PIP 3 21-23. 35 S-Met-labeled AKT-1 alone bound strongly to PIP 3 and weakly to cardiolipin and this binding was not affected by addition of unlabeled GST-CNT-1a or GST-CNT-1b (Fig. 5b) . Addition of GST-CNT-1a or GST-CNT-1b pre-treated with CED-3 completely blocked PIP 3 binding by AKT-1 (Fig. 5b) , whereas incubation of AKT-1 with CED-3 did not alter AKT-1 lipid binding (Fig. 5b) . Likewise, both AKT-2 and SGK-1 bound strongly to PIP 3 and this binding was blocked by GST-CNT-1a pre-treated with CED-3 (Fig. 5c ). To probe how tCNT-1 inhibits PIP 3 binding by AKT-1, we compared their PIP 3 binding affinity. We first determined the concentrations of 35 S-Met-labeled GST-tCNT-1a and AKT-1 synthesized in rabbit reticulocyte lysate (RRL) by comparing them with recombinant GST-tCNT-1a and AKT-1 proteins with known concentrations, which were purified from bacteria (Bact) but showed no lipid binding activity (Fig. 6a) . Labeled GST-tCNT-1a and AKT-1-His 6 displayed comparable radioactive signal intensity at the same concentrations (Fig. 6b) . GST-tCNT-1a displayed strong PIP 3 binding at 0.04 nM, weak binding at 0.004 nM, and no binding at 0.0004 nM (Fig. 6c) . By contrast, AKT-1 showed strong PIP 3 binding at 4 nM, weak binding at 0.4 nM, and no binding at 0.04 nM (Fig. 6c) , indicating that tCNT-1a binds PIP 3 with two order of magnitude higher affinity than AKT-1. Because the expression level of CNT-1 in C. elegans is approximately 70% higher than that of AKT-1 ( Supplementary Fig. 6 ), the combination of higher CNT-1 concentrations and much higher binding affinity to PIP3 than those of AKT-1 allows tCNT-1 to block PIP 3 binding by AKT kinases and thus their activation.
tCNT-1 translocates to plasma membrane upon CED-3 cleavage
Several proteins containing the PH domain translocate from cytosol to plasma membrane via a PIP 3 -mediated mechanism [45] [46] [47] . We analyzed subcellular localization of CNT-1 using an antibody raised against tCNT-1b ( Supplementary Fig. 1d ). CNT-1 localized in the cytoplasm of all cells in wild type embryos (Fig. 7a ) but was not detected in cnt-1(tm2313) embryos (Fig. 7b) , demonstrating the specificity of the antibody. In smIs82 (P hsp EGL-1) embryos that were induced to undergo global apoptosis and widespread CED-3 activation through heatshock treatment, CNT-1 staining was observed on the plasma membrane of all cells, in addition to staining in the cytoplasm ( Fig. 7d and Supplementary Fig. 7c, d ), indicating that a portion of CNT-1 translocated from cytosol to plasma membrane upon apoptosis activation. By contrast, in smIs82 embryos without heat-shock treatment or in smIs82; ced-3(n717) embryos with heat-shock treatment, CNT-1 remained in the cytoplasm (Fig. 7c , e and Supplementary Fig. 7a, b) , indicating that CNT-1 translocation from cytosol to plasma membrane is apoptosis-and CED-3-dependent. In cnt-1(tm2313); smIs82 embryos expressing CNT-1a(D1E), the CED-3 uncleavable form of CNT-1a, CNT-1a(D1E) did not translocate to the plasma membrane after heat-shock treatment ( Supplementary Fig. 7g-i) . By contrast, in cnt-1(tm2313); smIs82 embryos expressing CNT-1a, CNT-1a was observed on plasma membrane after heat-shock treatment ( Supplementary Fig. 7j-l) . These results confirm that CED-3 cleavage is required for CNT-1 translocation to plasma membrane during apoptosis. Consistently, loss of cnt-1 partially suppressed and expression of tCNT-1a enhanced ectopic cell death induced by smIs82 (Supplementary text and Supplementary Fig. 4c d) , providing further support to the finding that cleavage of CNT-1 and activation of tCNT-1 is an important downstream event of CED-3 activation and apoptosis.
tCNT-1 inhibits association of AKT-1 to the plasma membrane AKT-1 also contains a PH domain and its human homolog translocates to the plasma membrane through binding to PIP 3 48 . Given the limited amount of PIP 3 on the plasma membrane, the higher concentration of CNT-1 in vivo than AKT-1, and the much stronger PIP 3 binding affinity of tCNT-1 than that of AKT-1, we examined if tCNT-1 blocks AKT-1 translocation to the plasma membrane. The first 180 residues of AKT-1, including its PH domain (residues 15-118), were fused to GFP and expressed from the sur-5 gene promoter (P sur-5 AKT-1-PH::GFP). In wild type embryos carrying P sur-5 AKT-1-PH::GFP, GFP was diffuse within the cells (Fig. 7f) . When this transgene was crossed into daf-18(e1375) animals that are deficient in converting PIP 3 to PIP 2 and thus have elevated levels of PIP 3 , in the plasma membrane, bright GFP signals were seen on the plasma membrane, suggesting that AKT-1-PH::GFP translocated to the plasma membrane through binding to PIP 3 (Fig.  7g) . Expression of tCNT-1a abolished AKT-1-PH::GFP localization to the plasma membrane in daf-18(e1375) embryos (Fig. 7h) , indicating that tCNT-1 inhibited association of AKT-1 to the plasma membrane. Similarly, in smIs82; daf-18(e1375) animals carrying P sur-5 AKT-1-PH::GFP, some AKT-1-PH::GFP localized to the plasma membrane when without heat-shock treatment (Fig. 7i) . After heat shock treatment, AKT-1-PH::GFP disappeared from the plasma membrane (Fig. 7j) , indicating that endogenous tCNT-1 induced by smIs82 is sufficient to block AKT-1 association with plasma membrane and thus AKT-1 activation and function.
DISCUSSION
The physiological relevance of caspase substrates is an understudied area that limits our understanding of apoptosis. We have identified multiple components acting downstream of CED-3 to promote apoptosis using a sensitized CED-3 protease suppressor (cps) screen 35 . The cell death defects of each cps mutant are mild or undetectable, due to the fact that multiple CED-3 downstream pathways act in parallel to kill the cell [5] [6] [7] 35 . In this study, we characterized one of the cps genes, cps-2 (cnt-1), whose inactivation delays cell death and suppresses apoptosis in sensitized genetic backgrounds. Importantly, CNT-1 is a substrate of CED-3 both in vitro and in vivo. A mutation blocking CNT-1 cleavage by CED-3 abolishes its pro-apoptotic activity, whereas tCNT-1 alone is sufficient to induce apoptosis. These results establish that CNT-1 is an in vivo CED-3 target.
Despite containing a PH domain, a potential phosphoinositide-binding motif, CNT-1 does not bind any phospholipids in vitro or associate with plasma membrane in vivo. Upon activated by CED-3 cleavage during apoptosis, tCNT-1 acquires strong binding to phosphoinositides and translocates to the plasma membrane where it outcompetes AKT kinases for PIP 3 binding to block recruitment and activation of AKT kinases at the plasma membrane, thereby inactivating the AKT survival pathway to accelerate cell killing (Fig. 8) . Therefore, CED-3 activates a downstream death execution event by cleaving CNT-1, which then inactivates the AKT cell survival pathway. Our study elucidates a previously unknown, regulatory link between cell death execution and cell survival signaling.
Given the critical roles of the AKT kinases in cell growth, survival and metabolism, the activities of AKT kinases are tightly regulated at several different levels 9, 14 . Association of AKT with PIP 3 generated by PI3K at the plasma membrane is the critical first step, followed by sequential phosphorylation of AKT by PDK1 and mTORC2, leading to full activation of AKT. At each step, negative regulators are in place to fine-tune the level of AKT activation. The PTEN phosphatase converts PIP 3 back to PIP 2 , reducing or blocking AKT activation 49, 50 . Dephosphorylation of AKT by phosphatases, including protein phosphatase 2A and phosphatase PHLPP, also reduces or blocks AKT activation [51] [52] [53] [54] . In this study, we report a new mechanism that could rapidly shut down AKT at the level of PIP 3 binding and plasma membrane recruitment, through proteolytic activation of a PH-containing protein to generate a competing phosphoinositide-binding activity. Given the presence of hundreds of PH-domain proteins in eukaryotes with unknown functions 41 , this could be a general and conserved mechanism for regulating membrane-associated cell signaling or activity. There are several potential human CNT-1 homologs, ACAP1, ACAP2 and ACAP3, but none has been reported to have a role in apoptosis. It will be interesting to investigate if these ACAP proteins might act like CNT-1 to inhibit AKT survival signaling in humans.
AKT kinases and PI3K are required for the IIS pathway in C. elegans. Inactivation of these genes increases life span and stress resistance 32, 33 . Interestingly, loss of cnt-1 does not affect these two processes ( Supplementary Fig. 8 ), indicating that CNT-1 is an apoptosis-specific inhibitor of the PI3K and AKT pathway. AKT is a major drug target in treating cancer, however, clinical development of AKT inhibitors has been restricted by the fact that AKT is involved in multiple important cellular events, which inevitably will lead to numerous ontarget or off-target side effects 9, 14, 55 . Targeted inactivation of AKT in cancer cells to induce apoptosis through a CNT-1-like mechanism could present a new therapeutic strategy when combined with other anti-cancer therapies.
ONLINE METHODS
Strains and culture conditions
C. elegans strains were maintained using standard procedures 56 . The following alleles were used in the genetic analyses:
LGI, daf-16(mu86), ced-1(e1735), smIs13, smIs111; LGII,
dpy-10(e128), age-1(mg44), cnt-1(tm2313), cps-2(sm8), rol-1(e91); LGIII, daf-2(e1370), ced-4(n1162, n2273), smIs82; LGIV, daf-18(e1375), ced-3(n717, n2438), dpy-4(e1166);
LGV
, akt-1(mg144gf, tm399), him-5(e1490); LGX, akt-2(tm1075), sgk-1(ok538).
Isolation of the cps-2(sm8) mutation
Ethyl methane sulfonate (EMS) mutagenesis was performed on animals carrying an integrated transgene (smIs1) containing both P mec-7 acCED-3 and P mec-3 GFP 35 . P mec-7 acCED-3 drives acCED-3 expression in six mechanosensory neurons and the ectopic death of these non-essential neurons, which are also labeled by GFP (P mec-3 GFP). Progeny of the mutagenized animals were screened for mutants with increased survival of the fluorescent mechanosensory neurons. From a screen of 3,000 mutagenized haploid genomes, 
Quantification of cell corpses and extra cells
The number of cell corpses in living embryos and the number of extra cells in the anterior pharynx of L4 larvae were scored using Nomarski optics as described previously 35 .
CNT-1 antibody
Amino acids 1-298 of CNT-1b (tCNT-1b) fused with Glutathione S-transferase (GST) were expressed in Escherichia coli strain BL21(DE3) and affinity purified from the soluble fraction of the bacterial lysate using Glutathione Sepharose 4B beads (GE Helthcare). Rats were immunized with purified GST-tCNT-1b proteins (Spring Valley Laboratories, Inc.). CNT-1 antibodies were affinity purified from terminal bleeds using purified GST-tCNT-1a proteins as described previously 57 .
Immunoblotting analysis
C. elegans embryos were harvested with M9, centrifuged at 500 × g to remove bacteria, and then sonicated in the PBS buffer. After centrifugation at 25,400 × g to remove debris, 2 x SDS loading buffer was added and heated at 95° for 3 minutes. The samples were resolved with 15% SDS-PAGE and transferred to the PVDF membrane (Millipore). The membrane was first blocked with 5% nonfat dry milk in PBST (PBS + 0.1% Tween 20) and washed 2 times with PBST for 5 minutes each. The membrane was then incubated with affinitypurified anti-CNT-1 antibody in 1:1,000 dilution for 1 hour at room temperature and washed three times with PBST for 5 minutes each. It was then incubated with HRP-conjugated goat anti-rat IgG antibody (Jackson Immunoresearch #112-035-003; validation is provided on the manufacturer's website) with 1:2,000 dilution for 1 hour at room temperature, washed three times with PBST, and detected using enhanced chemiluminescent substrate (Pierce). For alpha-tubulin immunoblotting, anti-alpha-tubulin antibody (Developmental Studies Hybridoma Bank #AA4.3; validation is provided on the manufacturer's website) was used at 1:5,000 dilution and HRP-conjugated goat anti-mouse IgG antibody (Jackson Immunoresearch #115-035-003; validation is provided on the manufacturer's website) was used at 1:3,000 dilution. For anti-GST and anti-His 6 immunoblotting, a mouse anti-GST antibody (Santa Cruz Laboratory #sc-138; validation is provided on the manufacturer's website) or a rabbit anti-His 6 antibody (Santa Cruz Laboratory #sc-803; validation is provided on the manufacturer's website) was used at 1:2,000 dilution with a HRPconjugated goat anti-mouse IgG antibody or a HRP-conjugated goat anti-rabbit IgG antibody (Jackson Immunoresearch #111-035-003; validation is provided on the manufacturer's website) at 1:3,000 dilution. For anti-AKT-1 immunoblotting, an affinity purified goat anti-AKT-1 antibody (Bethyl Laboratories) 60 was used at 1:10,000 dilution with a HRP-conjugated donkey anti-goat IgG antibody (Jackson Immunoresearch #705-035-003; validation is provided on the manufacturer's website) at 1:10,000 dilution.
Heat shock experiments
The heat shock experiments were carried out as described previously 5 .
CED-3 cleavage assay
CED-3 protease assays were done as described previously 40 . Briefly, proteins of interest were synthesized and labeled with 35 S-Methionine using TNT Transcription and Translation coupled system (Promega) and incubated with or without 5 ng of purified CED-3 at 30°C for 1 hour. The reactions were then resolved by 15% SDS-PAGE gel and subjected to autoradiography.
Lipid binding assay
Various CNT-1 proteins were synthesized and labeled with 35 S-Methionine using the TNT system and incubated with or without purified CED-3 as described above. The membrane strip containing various lipids (Echelon Biosciences) was blocked in 3% fatty-acid free bovine serum albumin (Sigma) in PBST (PBS + 0.01% Tween 20) for 1 hour and washed 3 times with PBST. The membrane strip was then incubated with 2 μl of the reticulocyte lysate containing the protein of interest in PBST at 1:1,000 dilution for 1 hour at room temperature. After washing 3 times with PBST, the membrane strip was subjected to autoradiography. For the PIP 3 competition assay, AKT-1, AKT-2 and SGK-1 were synthesized and labeled with 35 S-Methionine, while GST-CNT-1 was synthesized with unlabeled Methionine. After GST-CNT-1 was pretreated with CED-3, the lysate containing 35 S-Methionine-labeled AKT-1 (20 μl) and the lysate containing unlabeled GST-CNT-1 (2 μl) were added to the membrane strip in 2 ml of PBST at the same time.
Determination of in vitro synthesized protein concentrations
The concentrations of GST-tCNT-1a and AKT-1-His 6 synthesized in rabbit reticulocyte lysate (also labeled by 35 S-Methionine*) were determined by the immunoblotting analysis, comparing the signal intensity of these proteins with that of recombinant GST-tCNT-1a (12 μg/ml) or AKT-1-His 6 (20 μg/ml) purified from bacteria. Recombinant GST-tCNT-1a or AKT-1-His 6 purified from bacteria did not show any lipid binding activity, probably due to misfolding of the proteins. Briefly, 5.1 μl of GST-tCNT-1a or 2.9 μl of AKT-1-His 6 synthesized in rabbit reticulocyte lysate (*RRL) or 1 pmol of GST-tCNT-1a or AKT-1-His 6 purified from bacteria (Bact) were resolved by 15% SDS-PAGE and subjected to immunoblotting analysis using an anti-GST or an anti-His 6 antibody as described in Immunoblotting analysis. Since the amounts of two GST-tCNT-1a proteins are comparable, the concentration of GST-tCNT-1a from RRL is approximately 196 nM. Since the amounts of two AKT-1-His 6 proteins are also comparable, the concentration of AKT-1-His 6 from RRL is approximately 345 nM.
Transgenic animals
Transgenic animals were generated as described previously 58 . P cnt-1 CNT-1a::3x flag or P cnt-1(sm8) CNT-1a::3xFlag was injected into cps-2(sm8) animals at 20 μg/ml along with the pTG96 plasmid (at 20 μg/ml) as a co-injection marker. The pTG96 plasmid contains a sur-5::gfp translational fusion that is expressed in all somatic cells at most developmental stages 59 . P dpy-30 CNT-1a, P dpy-30 CNT-1b, P dpy-30 CNT-1a(D1E), P dpy-30 CNT-1b(D1E), P dpy-30 tCNT-1a, P dpy-30 tCNT-1b, P dpy-30 CNT-1 F2, P dpy-30 CNT-1 F3, P dpy-30 CNT-1a(K284A), and P dpy-30 tCNT-1a(K284A) were injected into cnt-1(tm2313) animals at 20 μg/ml along with the pTG96 plasmid (at 20 μg/ml), respectively. Transgenic arrays containing P dpy-30 tCNT-1a were then crossed into the akt-1(mg144gf), age-1(mg44) or daf-16(mu86) mutant for further analyses. P sur-5 AKT-1-PH::GFP was injected into daf-18(e1375) animals at 20 μg/ml along with the pRF4 (at 20 μg/ml), a dominant rol-6 construct. One of the transgenic arrays was then crossed into N2 animals and smIs82; daf-18(e1375) animals or injected with P dpy-30 tCNT-1a at 20 μg/ml along with P sur-5 mCherry (at 20 μg/ml) as the second transgenic marker to generate transgenic animals containing both P dpy-30 tCNT-1a and P sur-5 AKT-1-PH::GFP. P dpy-30 AKT-1, P dpy-30 AKT-1(K222M), P dpy-30 AKT-2, or P dpy-30 AKT-2(K209M) was injected into akt-1(tm399)/nT1; akt-2(tm1075) animals at 20 μg/ml along with the pTG96 plasmid (at 20 μg/ml), respectively.
Molecular biology
Full-length cnt-1a cDNA and cnt-1b cDNA were amplified using reverse transcription polymerase chain reaction (RT-PCR) and then subcloned into the pET-41b vector via its Spe I and Not I sites to generate the pET-41b-CNT-1a and pET-41b-CNT-1b expression vector.
To construct various pET-41b-CNT-1 mutant expression vectors [pET-41b-CNT-1a(D1E), pET-41b-CNT-1a(D2E), pET-41b-CNT-1a(D3E), pET-41b-CNT-1b(D1E), pET-41b-CNT-1b(D2E), pET-41b-CNT-1b(D3E), and pET-41b-CNT-1a(K284A)], pET-41b-CNT-1a or pET-41b-CNT-1b was used as a DNA template to make the indicated amino acid substitutions using a Quick Change mutagenesis kit (Stratagene). pET-41b-tCNT-1a and pET-41b-tCNT-1b were constructed by subcloning PCR fragment coding for amino acids 1-382 of CNT-1a and 1-298 of CNT-1b into pET-41b via Spe I and EcoR V sites, respectively. To construct P cnt-1 CNT-1a::3x flag, a 1944 bp Sph I-Nhe I PCR fragment containing the cnt-1 promoter was fused with a 2640 bp Nhe I-Sma I PCR fragment containing the full-length cnt-1a cDNA, which was then subcloned into a modified pPD95.79 vector, in which the gfp coding region was replaced with a 3x flag sequence. To construct P dpy-30 CNT-1a and P dpy-30 CNT-1b, full-length cnt-1a and cnt-1b cDNAs were PCR amplified and subcloned into pS235 via its Sph I and Xma I sites, which contains the promoter of the C. elegans dpy-30 gene. Quick Change mutagenesis was then performed to obtain P dpy-30 CNT-1a(D1E) and P dpy-30 CNT-1b(D1E). P dpy-30 tCNT-1a and P dpy-30 tCNT-1b were constructed by subcloning PCR fragment coding for amino acids 1-382 of CNT-1a and 1-298 of CNT-1b into pS235 via its Nhe I and Xma I sites. To construct P dpy-30 CNT-1a F2 and P dpy-30 CNT-1a F3, PCR fragments coding for amino acids 383-609 and 610-826 of CNT-1a were subcloned into pS235 via Nhe I and Xma I sites. P dpy-30 CNT-1a(K284A) and P dpy-30 tCNT-1a(K284A) were generated by Quick Change mutagenesis. To construct pET-21b-AKT-1, pET-21b-AKT-2, and pET-21b-SGK-1 expression vectors, akt-1, akt-2, and sgk-1 full-length cDNAs were PCR amplified and subcloned into pET-21b through its Nhe I and Xho I sites. To construct P sur-5 AKT-1-PH::GFP expression vector, a PCR fragment coding for amino acids 1-180 of AKT-1 was subcloned into a modified pPD95.77 vector, which contains the promoter of the sur-5 gene. P dpy-30 AKT-1 or P dpy-30 AKT-2 was constructed by subcloning AKT-1 or AKT-2 cDNA fragment into the pS235 vector via its Nhe I and Sma I sites. Quick-change mutagenesis was then performed to generate kinasedefective mutants of AKT-1 and AKT-2 that contain K222M and K209M substitutions, respectively.
Determination of protein expression levels in C. elegans
200 wild-type N2 C. elegans embryos at 1.5-fold stage were collected in the PBS buffer and sonicated before adding 2 x SDS buffer. The N2 embryonic lysate and 1 pmol of GST-CNT-1a or AKT-1-His 6 proteins purified from bacteria were resolved by SDS-PAGE and subsequently subjected to immunoblotting using an affinity-purified anti-CNT-1 antibody or anti-AKT-1 antibody as described in Immunoblotting analysis, respectively. To determine the expression level from the immunoblotting images, the signal intensity of a protein band was measured using the ImageJ software and subtracted by the background intensity, the value of which was used to determine the average expression level of the protein.
Immunostaining on C. elegans embryos
Mix-stage C. elegans animals were harvested with M9, bleached with 12% NaOCl and 1.5 M NaOH, and centrifuged at 500 × g to remove bacteria and debris. Embryos were washed 3 times with ddH 2 O, mounted on poly-L-lysine coated slides, and frozen at −80° for 10 minutes. They were fixed with Methanol for 15 minutes on ice and washed with PBS before being stained with anti-CNT-1 antibody at 1:500 dilution in PBS for 1 hour. After the embryos were washed three times with PBS, they were stained with Alexa Fluor 488-conjugated anti-rat IgG antibody (Molecular Probes #A-11006; validation is provided on the manufacturer's website) at 1:1,000 dilution in PBS for 1 hour. They were then washed three times with PBS and visualized using an Axioplan 2 Nomarski Microscope (Carl Zeiss MicroImaging Inc.).
RT-PCR
The primer sequences for cnt-1 is: 5′ CTCTGTGCCAAGACTGGATGC-GGGC 3′ and 5′ CGTTGCCTGGGACGCGGCGGAC 3′, and the primer sequences for rpl-26 is: 5′ ATGAAGGTCAATCCGTTCGT 3′ and 5′ AGGACACGTCCAGTG-TTTCC 3′.
Lifespan analysis and thermo-tolerance assay
For lifespan analysis, animals were grown at 20° until the L4 larval stage and then transferred to new plates (10 animals per plates) at 25°. Animals were scored every day subsequently and moved periodically to keep growth conditions mold free. Animals were scored as dead if they failed to respond to a gentle tap on the head and tail with a platinum wire 21 . For thermo-tolerance assay, animals were grown at 20° until the L4 larval stage and then transferred to new plates (10 animals per plates) at 33°. Animals were scored every 2 hours for the first 24 hours, subsequently scored every 12 hours until 60 hours. Animals were scored as dead if they failed to respond to a gentle tap on the head and tail with a platinum wire. [1] ) used for mapping cps-2(sm8). Numbers below are the fractions of the 105 recombinant events that occur between two genetic markers and three SNPs, respectively. The bottom panel shows the cnt-1 coding region, the sm8 mutation, the tm2313 deletion, and rescuing results of the cps-2(sm8) mutant by the P cnt-1 CNT-1a::3xFlag and the P cnt-1(sm8) CNT-1a::3xFlag constructs. Three independent transgenic arrays were examined for each rescue experiment. (c) Embryonic cell corpses were counted in animals with the indicated genotype. In a and c, the y axis represents average number of cell corpses and error bars represent standard deviation (s.d.). Statistical significance values were determined by two-way ANOVA, followed by Bonferroni comparison (n = 15 embryos at each stage). * P < 0.001; ** P < 0.05. Cleavage of CNT-1 by CED-3 activates its proapoptotic activity. Cell corpses were scored in embryos with the indicated genotypes and at the indicated embryonic stages. The y axis represents the average number of cell corpses and error bars represent s.d. Statistical significance values were determined by two-way ANOVA, followed by Bonferroni comparison (n = 15 embryos at each stage). * P < 0.001. cnt-1 acts downstream of age-1 but upstream of akt-1, akt-2, and sgk-1 to promote apoptosis. Cell corpses were scored in the indicated strains as in Fig. 3 . The y axis represents average number of cell corpses and error bars represent s.d. Statistical significance values were determined by two-way ANOVA, followed by Bonferroni comparison (n = 15 embryos at each stage). * P < 0.001; ** P < 0.05. A model of CED-3-activated suppression of AKT signaling by CNT-1 in C. elegans. In nonapoptotic cells, some AKT kinases are recruited to the plasma membrane and activated by PIP 3 to transduce the survival signal. In apoptotic cells, CNT-1 is cleaved by activated CED-3 to generate potent phosphoinositide-binding tCNT-1, which translocates to the plasma membrane from the cytoplasm. tCNT-1 outcompetes AKT kinases for binding to PIP 3 and thus displaces and inactivates AKT kinases, leading to loss of the survival signal and apoptosis.
